title: Pathophysiological effects of glucocorticoids on nasal polyps: an update.
abstract: OBJECTIVE
  The exact mechanisms by which glucocorticoids exert their beneficial effects on nasal polyps are not clearly defined. Nasal polyps, asthma and allergic rhinitis share common features such as mucosal infiltration with eosinophils and mast cells as well as local IgE production. The present review is an update on the pathophysiological mechanisms of glucocorticoids on nasal polyps described during the last 2 years.
  
  
  RESULTS
  The reduction of leukocyte numbers in nasal polyps following glucocorticoid treatment depends on several mechanisms, for example altered balance between the two isoforms of the human glucocorticoid receptors, GRalpha and GRbeta. Another explanation may be inhibition of CD4+ T by CD8+ T cells. Increased expression of the antiinflammatory cytokine transforming growth factor beta may contribute to this. A DNA microarray study which examined the expression of some 22 000 genes showed increased expression of several antiinflammatory genes in nasal polyps after treatment with glucocorticoids. The antiinflammatory gene that increased most was uteroglobin (also known as Clara cell protein 16) which is abundantly expressed in airway secretions and thought to have an important role in regulating inflammation.
  
  
  CONCLUSIONS
  Glucocorticoids affect both pro and antiinflammatory pathways in nasal polyps. Upregulation of antiinflammatory genes such as transforming growth factor beta and uteroglobin may play an important role. Elucidation of these mechanisms may help us to understand not only the effects of glucocorticoids on nasal polyps, but also on related disorders such as allergic rhinitis and asthma.
authors.affiliation: Pediatric Allergy Research Group, Queen Silvia Children's Hospital, Gothenburg, Sweden. mikael.benson@vgregion.se
authors.forename: Mikael
authors.initials: M
authors.lastname: Benson
mesh_terms: D016207:Cytokines / Q000235:genetics / Q000276:immunology; D005938:Glucocorticoids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009298:Nasal Polyps / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology; D020411:Oligonucleotide Array Sequence Analysis
chemical_list: D016207:Cytokines; D005938:Glucocorticoids